Raymond Pratt - Nov 21, 2022 Form 4 Insider Report for Savara Inc (SVRA)

Role
Chief Medical Officer
Signature
/s/ Kathleen McCabe as attorney-in-fact for Raymond D. Pratt
Stock symbol
SVRA
Transactions as of
Nov 21, 2022
Transactions value $
$0
Form type
4
Date filed
11/22/2022, 03:08 PM
Previous filing
Nov 16, 2022
Next filing
Dec 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SVRA Common Stock Award $0 +150K $0.00 150K Nov 21, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SVRA Stock Option (Right to Buy) Award $0 +375K $0.00 375K Nov 21, 2022 Common Stock 375K $1.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that vest in full on November 10, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of November 10, 2022, subject to the reporting person's continued service with the Issuer.